Resources Contact Us Home
Concentrated, non-foaming solution of quarternary ammonium compounds and methods of use

Image Number 5 for United States Patent #6864269.

A concentrated quaternary ammonium compound (QAC) solution comprising a QAC with a concentration from greater than about 10% by weight and at least one solubility enhancing agent, such as an alcohol, is disclosed. A diluted QAC solution is used to contact food products to prevent microbial growth on the food products from a broad spectrum of foodborne microbial contamination. A method of contacting the food products with the dilute QAC for an application time of at least 0.1 second is disclosed. The foods that can be treated by this method are meat and meat products, seafood, vegetables, fruit, dairy products, pet foods and snacks, and any other food that can be treated and still retain its appearance and texture. One of the treatment methods is spraying and misting the QAC solutions on the food products for an application time of at least 0.1 second to prevent broad spectrum foodborne microbial contamination.

  Recently Added Patents
Method for capture, aggregation, and transfer of data to determine windshield wiper motion in a motor vehicle
Method of relaying data
Detection of RNA in tissue samples
Device for pasteurizing a mass of foodstuff
Portable electronic apparatus functioning as pen-table and computer system using the same
Sensor installations for motorized vehicle doors
Multi-platform presentation system
  Randomly Featured Patents
Cross-diffusion resistant dual-polycide semiconductor structure and method
Preparation of oxygenated ambroxides
Wire nut
Method of displaying information by using an LC resonance tag
Circuit and method for measuring the performance parameters of transistors
Process and device for the radio transmission of signals generated near the body
Securities market and market maker activity tracking system and method
Liquid crystal displays with laminated diffuser plates
Liquid transfer system for conductive liquids
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen